Stratos Wealth Partners LTD. Sells 4,942 Shares of Astera Labs, Inc. $ALAB

Stratos Wealth Partners LTD. reduced its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 19.5% in the third quarter, HoldingsChannel reports. The institutional investor owned 20,461 shares of the company’s stock after selling 4,942 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Astera Labs were worth $4,006,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in ALAB. Great Valley Advisor Group Inc. increased its position in shares of Astera Labs by 2.2% in the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after acquiring an additional 90 shares during the period. Straight Path Wealth Management boosted its holdings in shares of Astera Labs by 1.5% during the second quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock worth $619,000 after purchasing an additional 100 shares during the period. Rye Brook Capital LLC grew its stake in shares of Astera Labs by 1.1% in the third quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock worth $1,801,000 after purchasing an additional 100 shares during the last quarter. First Horizon Advisors Inc. grew its stake in shares of Astera Labs by 12.4% in the second quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock worth $89,000 after purchasing an additional 108 shares during the last quarter. Finally, SlateStone Wealth LLC increased its holdings in Astera Labs by 1.3% during the 3rd quarter. SlateStone Wealth LLC now owns 12,744 shares of the company’s stock valued at $2,495,000 after purchasing an additional 160 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Up 2.2%

ALAB opened at $129.32 on Friday. The company has a market cap of $21.84 billion, a price-to-earnings ratio of 106.00, a price-to-earnings-growth ratio of 2.74 and a beta of 1.50. The stock has a fifty day simple moving average of $164.09 and a two-hundred day simple moving average of $174.12. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The company’s quarterly revenue was up 91.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 results beat consensus (revenue and EPS ahead) and management gave solid Q1 guidance, supporting the growth narrative tied to AI/hyperscaler demand. ALAB Stock Dips 31% Post Q4 Earnings
• Positive Sentiment: Northland Securities reiterated an Outperform rating and published multi-quarter EPS projections plus a $195 price target — a bullish analyst signal that supports upside if execution continues. MarketBeat – Northland Estimates
• Neutral Sentiment: Several deep-dive writeups and the Q4 earnings transcript are available for investors parsing the details (growth, product cadence, Scorpio X timing). These are useful for assessing whether margin pressures are one-off or structural. Earnings Call Transcript
• Neutral Sentiment: Short-interest reports in the feed show anomalous “0 shares / NaN” values across dates — data appears erroneous and provides no reliable signal on short pressure. (Treat short-interest figures cautiously.)
• Negative Sentiment: Investors sold aggressively after management flagged margin headwinds and rising operating expenses; multiple outlets report a sharp post-earnings drop as traders re-priced the stock despite the beat. ALAB Stock Slides
• Negative Sentiment: Analyst downgrade / notes and reports of a gap-down move amplified the sell-off — negative research and headlines can pressure sentiment even when fundamentals look strong. Shares Gap Down Following Analyst Downgrade
• Negative Sentiment: Coverage pieces explain the paradox: stellar revenue growth but margin guidance and near-term opex make the print look less clean, prompting profit-taking and volatility. Why Stock Crashed Despite Strong Earnings

Insider Buying and Selling at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 4,620 shares of the company’s stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $668,467.80. Following the sale, the general counsel owned 147,040 shares in the company, valued at approximately $21,275,217.60. This represents a 3.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Manuel Alba sold 150,000 shares of Astera Labs stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the transaction, the director owned 1,574,498 shares of the company’s stock, valued at $261,650,077.64. The trade was a 8.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 576,936 shares of company stock valued at $87,409,540 over the last three months. 12.50% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have weighed in on ALAB. Citigroup dropped their price objective on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday. Royal Bank Of Canada began coverage on Astera Labs in a research note on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target for the company. Raymond James Financial initiated coverage on shares of Astera Labs in a report on Friday, November 21st. They issued a “hold” rating on the stock. Stifel Nicolaus boosted their price objective on shares of Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a research report on Wednesday, December 3rd. Fourteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $192.89.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.